Male and Female Sexual Dysfunction

	List Price: $65.00 Our Price: $111.05 Availability: N/A
Manufacturer: Mosby Written By: Allen D. Seftel, Harin Padma-Nathan, Christopher G. McMahon, Francois Giuliano, Stanley E. Althof	Click on the Buy From Amazon.com link to know Amazon.com's best price & availability.
Binding: Hardcover Dewey Decimal Number: 616.69 EAN: 9780723432661 ISBN: 072343266X Label: Mosby Manufacturer: Mosby Number Of Items: 1 Number Of Pages: 312 Publication Date: 2004-05-21 Publisher: Mosby Studio: Mosby
Editorial Reviews for Male and Female Sexual Dysfunction Provides an authoritative, comprehensive and clinically-orientated guide to both the background causes and full range of treatment options for patients suffering from impotence and sexually-related dysfunction. The book is a concise and practical text, enhanced with specially commissioned computer graphics and full color illustrations. It is one of the first titles to comprehensively cover the new developments in treatment of female sexual dysfunction. Throughout, there is a wealth of information on new therapies, and the very latest information on drug treatment. The book includes innovative treatment algorithms, summary boxes, and patient vignettes, and has been produced to a tight time-frame to ensure a current approach. Encompasses the very latest developments in the field, thanks to an especially brief production schedule. Discusses the neuroanatomy and physiology of male and female sexual response, and evaluates the role of factors such as hormones, diabetes, hypertension, and depression in causing sexual dysfunction. Explores new oral therapies for male and female sexual dysfunction new therapies for ejaculation dis¬orders, including rapid ejaculation MUSE and intracavernosal therapies vacuum devices, gels, injections, and penile implants gene therapy and future directions in treatment. Presents specially commissioned computer graphics and full-color illustrations that make pathophysiology and treatment principles easy to understand.

Comprehensive Review of Sexual Medicine 2007 - Home
5th Comprehensive Review of Sexual Medicine. This meeting will continue to provide a complete review of male and female sexual dysfunction aimed at the practicing physician ...

International Journal of Impotence Research
... Journal of Sexual Medicine is a print and online publication dedicated to providing the latest research in the field of sexual medicine including male and female sexual dysfunction ...

Bremelanotide - Wikipedia, the free encyclopedia
On May 13, 2008, Palatin Technologies announced it "has discontinued development of Bremelanotide for the treatment of male and female sexual dysfunction".

NFB - Male and Female Sexual Dysfunction
National Federation of the Blind, the leading force in the blindness field today, has 50,000 members, 700 local chapters, 52 affiliates. Fosters self-respect and self-expression of ...

Diabetes.net - Home
9. male and female sexual dysfunction (including ED), 10. metabolically induced depression and chronic fatigue. 11. And other less quantitated symptoms of diabetes.

Bremelanotide - The Female Viagra?
Is Bremelanotide the new Female Viagra - A Revolution in Human Sexuality. Bremelanotide was Palatin Technologies drug candidate for treatment of male and female sexual dysfunction.

HSAB.org - What We Do > India Conference Video Interviews
It was on the overview of the male and female sexual dysfunction. I was mainly covering all aspects of male and female sexual dysfunction, particularly with emphasis on our latest ...

Connecticut Urologist - Adult & Pediatric Urology of Northwest ...
Male and Female Sexual Dysfunction - "No-Scalpel" Vasectomies - Bladder Control - Kidney Stones - Male Infertility - Prostate Problems - Premature Ejaculation

William J. Somers, MD, FACS - Urology - Welcome
Somers is a specialist in Male infertility, male and female sexual dysfunction, male hormone problems and painful bladder syndrome. At Mainstream Urology Center, we offer experience ...

Palatin Technologies - The Leader in Melanocortin-based Therapeutics
Overview PT-141. PT-141 is Palatin’s novel drug candidate for the treatment of male and female sexual dysfunction. First in a new class of therapies called melanocortin ...